BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Simultaneously inhibiting ASM and activating GHSR for Alzheimer’s 

By biocentury staff
February 11, 2022 9:02 PM UTC

DISEASE CATEGORY: Neurology

INDICATION: Alzheimer’s disease...

BCIQ Company Profiles

Kyungpook National University

BCIQ Target Profiles

Ghrelin receptor (GHSR)

Sphingomyelin phosphodiesterase 1 acid lysosomal (SMPD1) (ASM)

BCIQ Company Profiles

Kyungpook National University

BCIQ Target Profiles

Ghrelin receptor (GHSR)

Sphingomyelin phosphodiesterase 1 acid lysosomal (SMPD1) (ASM)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS